These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26096369)

  • 21. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
    Reeves MF; Monmaney JA; Creinin MD
    Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Jan; 83(1):62-7. PubMed ID: 21134505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound diagnosis of uterine dehiscence following mifepristone/misoprostol regime in early second trimester termination.
    El-Matary A; Navaratnarajah R; Economides DL
    J Obstet Gynaecol; 2006 Aug; 26(6):578-80. PubMed ID: 17000517
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
    Tamang A; Puri M; Lama K; Shrestha P
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mifepristone (RU 486) in the United States. What does the future hold?
    Rosenfield A
    N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient medical abortion is safe and effective through 70 days gestation.
    Abbas D; Chong E; Raymond EG
    Contraception; 2015 Sep; 92(3):197-9. PubMed ID: 26118638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the feasibility of obtaining mifepristone and misoprostol from the internet.
    Murtagh C; Wells E; Raymond EG; Coeytaux F; Winikoff B
    Contraception; 2018 Apr; 97(4):287-291. PubMed ID: 29030227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
    Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
    Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
    Chen AY; Mottl-Santiago J; Vragovic O; Wasserman S; Borgatta L
    Contraception; 2006 Apr; 73(4):415-9. PubMed ID: 16531178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosing interval of 24hours versus 48hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy.
    Chaudhuri P; Mandal A; Das C; Mazumdar A
    Int J Gynaecol Obstet; 2014 Feb; 124(2):134-8. PubMed ID: 24262683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
    Hou S; Zhang L; Chen Q; Fang A; Cheng L
    Int J Gynaecol Obstet; 2010 Nov; 111(2):126-30. PubMed ID: 20705290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and Safety of Lower Doses of Mifepristone Combined With Misoprostol for the Termination of Ultra-Early Pregnancy: A Dose-Ranging Randomized Controlled Trial.
    Li CL; Chen DJ; Song LP; Wang Y; Zhang ZF; Liu MX; Chen WL
    Reprod Sci; 2015 Jun; 22(6):706-11. PubMed ID: 25394644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(29):724. PubMed ID: 16049422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
    Tamang A; Tamang J
    Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2006 Oct; 26(7):679-81. PubMed ID: 17071439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
    Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
    J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical options for early pregnancy termination.
    Gold M; Luks D; Anderson MR
    Am Fam Physician; 1997 Aug; 56(2):533-8. PubMed ID: 9262533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.